Kevin Young
2013
In 2013, Kevin Young earned a total compensation of $5.4M as Former Executive Vice President, Commercial Operations at Gilead Sciences, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $978,000 |
|---|---|
| Option Awards | $1,449,962 |
| Salary | $810,424 |
| Stock Awards | $2,148,828 |
| Other | $7,500 |
| Total | $5,394,714 |
Young received $2.1M in stock awards, accounting for 40% of the total pay in 2013.
Young also received $978K in non-equity incentive plan, $1.4M in option awards, $810.4K in salary and $7.5K in other compensation.
Rankings
In 2013, Kevin Young's compensation ranked 1,137th out of 12,286 executives tracked by ExecPay. In other words, Young earned more than 90.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,137 out of 12,286 | 91st |
Division Manufacturing | 371 out of 4,612 | 92nd |
Major group Chemicals And Allied Products | 98 out of 1,462 | 93rd |
Industry group Drugs | 62 out of 1,156 | 95th |
Industry Biological Products, Except Diagnostic Substances | 7 out of 196 | 96th |
Source: SEC filing on March 24, 2014.
Young's colleagues
We found four more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2013.